Literature DB >> 17621360

Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis.

Troy D Jaskowski1, Eric Q Konnick, Edward R Ashwood, Christine M Litwin, Harry R Hill.   

Abstract

Our objectives in this study were to compare results obtained by an enzyme immunoassay (EIA) for F-actin antibody (FAA) immunoglobulin G (IgG) to those determined by an indirect fluorescent antibody (IFA) assay for smooth muscle antibody (SMA) IgG, and to determine the prevalence of FAA in patient sera having serologic evidence of acute viral hepatitis. Sera from 415 patients suspected of having autoimmune hepatitis (AIH), 208 patients suspected of having acute viral hepatitis A, B, or C, and 100 healthy blood donors (HBD) were included in the study. Only one of 100 HBD showed low levels (20-30 Units) of F-actin IgG. In patients suspected of having AIH, the prevalence of FAA increased as SMA titers increased and all sera with SMA titers of >or=1:160 were FAA-positive. In contrast, there were many sera with negative (<1:20) or low (1:20-1:40) SMA titers that contained moderate to high levels (>30 Units) of FAA; many exceeding 80 Units. Moreover, 51.4% of these sera were also positive for anti-nuclear antibody (ANA), which is also utilized in diagnosing type 1 AIH. FAA was detected in 25% of viral hepatitis antibody-positive sera, with the majority (59.3%) containing low levels, and all were ANA-negative. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621360      PMCID: PMC6649187          DOI: 10.1002/jcla.20167

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  19 in total

1.  Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA.

Authors:  A Zamanou; A Tsirogianni; C Terzoglou; A Balafas; I Economidou; P Lymberi
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Smooth muscle antibodies and type 1 autoimmune hepatitis.

Authors:  Paolo Muratori; Luigi Muratori; Daniela Agostinelli; Georgios Pappas; Lorenza Veronesi; Alessandro Granito; Fabio Cassani; Paolo Terlizzi; Marco Lenzi; Francesco B Bianchi
Journal:  Autoimmunity       Date:  2002-12       Impact factor: 2.815

3.  Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins.

Authors:  G Dighiero; P Lymberi; C Monot; N Abuaf
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

4.  Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis.

Authors:  A J Czaja; F Cassani; M Cataleta; P Valentini; F B Bianchi
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

5.  Anti-actin antibodies: a new test for an old problem.

Authors:  M Fusconi; F Cassani; D Zauli; M Lenzi; G Ballardini; U Volta; F B Bianchi
Journal:  J Immunol Methods       Date:  1990-06-12       Impact factor: 2.303

6.  Diagnostic value of anti-F-actin antibodies in a French multicenter study.

Authors:  P Chretien-Leprince; E Ballot; C Andre; N O Olsson; N Fabien; A Escande; F Oksman; S Dubuquoi; S Jego; J Goetz; A Chevailler; M Sanmarco; R L Humbel; C Johanet
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 7.  Anti-actin antibodies.

Authors:  A Fagraeus; R Norberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

Review 8.  Smooth muscle autoantibodies and autoantigens.

Authors:  B H Toh
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

9.  Classification of smooth muscle autoantibodies detected by immunofluorescence.

Authors:  G F Bottazzo; A Florin-Christensen; A Fairfax; G Swana; D Doniach; U Groeschel-Stewart
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

10.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

Authors:  Miriam J Alter; Wendi L Kuhnert; Lyn Finelli
Journal:  MMWR Recomm Rep       Date:  2003-02-07
View more
  2 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 2.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.